Reviews

 
Recommend
Trust
Listening
 
« 1 2 3 4 5 6 7 »
Page 1 of 9
 
28th March 2024


From start to finish both Katie his private secretary and Dr.Gharib were first class. Dr.Gharib kind, sensitive, exceedingly knowledgeable and explained matters in a simple and clear way. I would be very happy to recommend both as professional and courteous. MG

Recommend
Trust
Listening
 
25th February 2024


Brilliant attentive service and care

Recommend
Trust
Listening
 
9th January 2023


Despite the uncertain situation following my symptoms and possible diagnosis, Dr Gharib put me at total ease. He was so friendly and calming. He explained everything clearly so I knew exactly what was going on and what the next steps were. Thankfully my diagnosis proved to be a false alarm but despite that Dr Gharib could not have done more to make me feel as comfortable as possible. I would wholeheartedly recommend Dr Gharib should anyone be looking for a consultant in his field.

Recommend
Trust
Listening
 
Written by a NHS patient at Avondale Unit
15th March 2022


Dr Gharib has always been very helpful and understanding, he has been absolutely brilliant and I couldn't recommend him enough.

Recommend
Trust
Listening
 
21st February 2022


The first time I saw Dr Gharib I was impressed by his manner. Any qualms I had about seeing a consultant were immediately vanished. The five star answers to the above questions say it all. I remember particularly during the covis lock-down he was quite prepared to answer general health questions, not just those within his own particular remit.

Recommend
Trust
Listening
 
 

« 1 2 3 4 5 6 7 »
Page 1 of 9

Profile

Dr Gharib has been a Consultant Haematologist since 2005. He has a long experience in diagnosing and treating various benign and malignant blood disorders including leukaemias, lymphomas and myelomas since 1998. Dr Gharib is also the clinical lead in thrombosis and anti-coagulation in STHK NHS Trust. He is interested in studying and managing patients' risk of thrombosis. He is the principal investigator for the first national trial looking at treating cancer induced thrombosis with the new oral anti-coagulant, Rivaroxaban.

Dr. Gharib has a background experience in internal medicine from 1991 to 1998 which provides an excellent foundation in analysing patients symptoms and wider horizon in diagnosis and management.
He has published a wide range of research papers, case reports and textbook chapters and prides himself in the level of clinical and patient care.